Supernus Pharmaceuticals (SUPN) Change in Inventory (2012 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Change in Inventory of $306000.0 for Q2 2026, up 106.26% year-over-year from $148355.4 in Q2 2025, and up 191.43% on a QoQ basis from $105000.0 in Q1 2026.
Supernus Pharmaceuticals (SUPN) Change in Inventory (2012 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Change in Inventory for 15 years, with the latest figure at $306000.0 in Q2 2026.
- Change in Inventory for Q2 2026 came in at $306000.0, up 106.26% year-over-year; the trailing twelve-month figure through Jun 2026 was $17.5 million (up 200.7% YoY), and the FY2025 annual result was $7.5 million, up 147.46% from the prior year.
- Change in Inventory improved to $306000.0 in Q2 2026, from $105000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $12.9 million in Q3 2025 and troughed at -$6.9 million in Q3 2023.
- A 5-year average of $214166.7 and a median of -$942500.0 in 2024 frame the typical range for Change in Inventory.
- The widest annual swing landed in 2022, when Change in Inventory jumped 489.86%; it then tumbled 251.42% in 2024.
- A 5-year view of Change in Inventory shows it stood at $11.6 million in 2022, then plunged by 143.52% to -$5.0 million in 2023, then jumped by 36.61% to -$3.2 million in 2024, then surged by 231.16% to $4.2 million in 2025, then sank by 92.68% to $306000.0 in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $306000.0 in Q2 2026, $105000.0 in Q1 2026, and $4.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | 306,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 306,000.00 |
| Jun 30, 2026 | 306,000.00 |
| Mar 31, 2026 | 105,000.00 |
| Mar 31, 2026 | 105,000.00 |
| Dec 31, 2025 | 4.18 Mn |
| Dec 31, 2025 | 4.18 Mn |
| Sep 30, 2025 | 12.94 Mn |
| Sep 30, 2025 | 12.94 Mn |
| Jun 30, 2025 | -4.89 Mn |
| Jun 30, 2025 | -4.89 Mn |
| Mar 31, 2025 | -4.73 Mn |
| Mar 31, 2025 | -4.73 Mn |
| Dec 31, 2024 | -3.19 Mn |
| Dec 31, 2024 | -3.19 Mn |
| Sep 30, 2024 | -4.60 Mn |
| Sep 30, 2024 | -4.60 Mn |
| Jun 30, 2024 | -6.03 Mn |
| Jun 30, 2024 | -6.03 Mn |
| Mar 31, 2024 | -1.99 Mn |
| Mar 31, 2024 | -1.99 Mn |